По всем вопросам звоните:

+7 495 274-22-22

УДК: 616.98:578.2 DOI:10.33920/med-08-2109-01

Epidemiology of the current coronovirus infection: features and problems

Nechaev Vitaliy Vladimirovich PhD in Medicine, professor of the Department of Infectious Diseases, FSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russia, 47, Piskarevsky ave., St. Petersburg, 195067, e-mail: nechaev-tropica@mail.ru, https://orcid.org/0000-0002-5731-5818
Lobzin Yuriy Vladimirovich PhD in Medicine, professor, member of the Russian Academy of Sciences, director of the FSBI Children's Scientific and Clinical Center for Infectious Diseases of the FMBA of Russia, head of the Department of Infectious Diseases, FSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russia, 47, Piskarevsky ave., St. Petersburg, 195067, e-mail: niidi@niidi.ru, https://orcid.org/0000-0002-6934-2223
Gusev Denis Aleksandrovich PhD in Medicine, professor, chief physician, S. P. Botkin Clinical Infectious Diseases Hospital, 3, Mirgorodskaya str., St. Petersburg, 191167, e-mail: kibbotkin@mail.ru, https://orcid.org/0000-0001-9202-3231
Vasilieva Yuliya Anatolievna infectious disease doctor, S. P. Botkin Clinical Infectious Diseases Hospital, 49, Piskarevsky ave., St. Petersburg, 191167, e-mail: Vj1975@yandex.ru, https://orcid.org/0000-0001-9386-100Х
Vinogradova Nadezhda Valerievna infectious disease doctor, S. P. Botkin Clinical Infectious Diseases Hospital, 49, Piskarevsky ave., St. Petersburg, 191167, e-mail: nadywinni@rambler.ru, https://orcid.org/0000-0001-5398-7062
Tagirova Enzhe Rafikovna 6th year student, Faculty of General Medicine, FSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russia, 47, Piskarevsky ave., St. Petersburg, 195067, e-mail: tagirova enzhe@mail.ru, https://orcid.org/0000-0003-1412-3047
Gorziy Egor Sergeevich 5th year student, Faculty of Medicine and Prevention, FSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russia, 47, Piskarevsky ave., St. Petersburg, 195067, e-mail: egorziy@yandex.ru, https://orcid.org/0000-0003-4195-679Х
Pavlov Igor Alekseevich 5th year student, Faculty of Medicine and Prevention, FSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russia, 47, Piskarevsky ave., St. Petersburg, 195067, e-mail: alma.mater.1998@mail.ru, https://orcid.org/0000-0001-9436-6879
Shirokova Anna Yurievna 5th year student, Faculty of Medicine and Prevention, FSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russia, 47, Piskarevsky ave., St. Petersburg, 195067, e-mail: salander98@mail.ru, https://orcid.org/0000-0002-6513-5358
Yaremchuk Mariya Sergeevna 5th year student, Faculty of Medicine and Prevention, FSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russia, 47, Piskarevsky ave., St. Petersburg, 195067, e-mail: maria_01.05.1998@mail.ru, https://orcid.org/0000-0002-1639-9488
Yatsenko Anastasiya Mikhailovna 5th year student, Faculty of Medicine and Prevention, FSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of Russia, 47, Piskarevsky ave., St. Petersburg, 195067, e-mail: www.tan1973@mail.ru, https://orcid.org/0000-0003-4656-949Х

The research gives data on the epidemiological analysis of all COVID-19 cases in the WHO's and Russian regions over 2020-2021 and monitoring of diseases registered by the WHO all over the world and on the Stopcoronavirus Internet resources in Russia from January 2020 to May 2021. To assess the epidemiological situation, registration data were used in absolute numbers from 209 daily and more than 40 weekly reports of the World Health Organization from January 21 to May 30, 2021. The intensive indicators of morbidity and mortality were calculated, which made it possible to identify the regions and countries most affected by coronavirus infection and the peculiarities of the epidemic process in them.

Литература:

1. WHO. Сoronavirus disease (COVID19). Sitrep. 2020: 1-200. Available at: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019

2. Feng Z., Li Q., Zhang Y. et al. The epidemiological Characteristics of an Outbreak of 2019 novel coronavirus Diseases (COVID-19) - China 2020. China CDC Weekly 2020; 2 (8): 113-122.

3. Schnirring L. Report: Thailand's coronavirus patient didn't visit outbreak market. CIDRAP (14 January 2020). Available at: https://www.cidrap.umn.edu/newsperspective/2020/01/report-thailands-coronavirus-patient-didnt-visit-outbreak-market

4. WHO. Coronavirus disease 2019 (COVID-19) Situation Report 11. Available at: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019

5. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 265-269.

6. Revision of the International Health Regulations. 58 session of the World Health Assembly. May 23, 2005 WHO. Edition 3. 2016: 73 Available at: https://www.who.int/csr/ihr/WHA58-ru.pdf

7. Wu Z, Mc Googan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. doi: 10.1001/jama.2020.2648.

8. Semenov A.V., Pshenichnaya N. Yu. Lessons of the COVIND-19 epidemic in Italy. Infekcija i immunitet.2020; 10 (3):410-420. doi: http://dx.doi.org/10.15789/2220-7619-LTL1468

9. WHO. Coronavirus disease 2019 (COVID-19) Situation Reports №1-209. Available at: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019

10. Danilenko D. M., Komissarov A.V., Stukova M. A., Lioznov D. A. To be or not to be: forecast of the development of the COVID-19 epidemic in Russia. Zhurnal infektologii. 2020; 12(3): 6-11.

11. Popova A. Yu., Yezhlova E. B., Melnikova A. A., Balakhonov S. V., Chesnokova M. V., Dubrovina V. I., Lyalina L. V., Smirnov V. S., Trukhina A. G., Perezhogin A. N., Pentecostnikova A. B., Bryukhova D. D., Kiseleva N. O., Gefan N. G., Gavrilova O. V., Gavrilova T. A., Lomonosova V. I., Totolyan A. A. Experience in the study of seroprevalence to the Sars virus-cov-2 of the population of the Irkutsk region during the Covid-19 outbreak. Problemy osobo opasnyh infekcij. 2020;3: 106-113.

12. Popova A. Yu., Yezhlova E. B., Melnikova A. A., Kutyrev V. V., Kozhanova O. I., Cherkasskaya T. S., Lyalina V. I., Smirnov V. S., Bugorkova S. A., Portenko S. A., Naidenova E. V., Shcherbakova S. A., Lomonosova V. I., Totolyan A. A. Characteristics of population immunity to Sars-cov-2 in residents of Saratov and the Saratov region during the Covid-19. Problemy osobo opasnyh infekcij. 2020 epidemic; 4: 106-116.

13. Popova A. Yu., Ezhlova E. B., Melnikova A. A., Noskov A. K., Kovalev E. V., Karpushchenko G. V., Lyalina L. V., Smirnov V. S., Chemisova O. S., Trishina A.V., Bereznyak E. A., Volovikova S. V., Stenina S. I., Yanovich E. G., Meloyan M. G., Asmolova N. Yu., Usova A. A., Sly S. S., Totolyan A. A. Assessment of population immunity to Sars-cov-2 on the territory of the Rostov region. Problemy osobo opasnyh infekcij. 2020; 4: 117-124.

14. Popova A. Yu., Yezhlova E. B., Melnikova A. A., Historian O. A., Mosevich O. S., Lyalina L. V., Smirnov V. S., Cherny M. A., Balabysheva N. S., Loginova I. S., Vladimirova O. S., Samoyadova I. S., Vasev N. A., Rumyantseva S. V., Chupalova E. Yu., Selivanova G. V., Muravyeva M. V., Timofeeva L. V., Khankishieva E. N., Tylchevskaya V. D., Nikitenko N. D., Kostenitskaya T. I., Virkunen N. V., Klimkina I. M., Kuzmina T. M., Degtyarenko N. V., Bazunova A. I., Filippova L. A., Palchikova N. A., Kukshkin A.V., Arsentieva N. A., Batsunov O. K., Bogumilchik E. A., Voskresenskaya E. A., Drobyshevskaya V. G., Zueva E. V., Kokorina G. I., Kurova N. N., Lyubimova N. E., Ferman R. S., Khamdulaeva G. N., Khamitova I. V., Khorkova E. V., Milichkina A.M., Dedkov V. G., Totolyan A. A. Assessment of population immunity to Sars-cov-2 among the population of the Leningrad region during the Covid-19 epidemic. Problemy osobo opasnyh infekcij.2020; 3: 114-123.

15. Popova A. Yu., Ezhlova E. B., Melnikova A. A., Andreeva E. E., Kombarova S. Yu., Lyalina L. V., Smirnov V. S., Aleshkin A.V., Kobzeva Yu. V., Ignatova E. N., Osadchaya M. N., Nazarenko E. V., Antipova L. N., Basov A. A., Zatevalov A.M., Novikova L. I., Bochkareva S. S., Likhanskaya E. I., Lomonosova V. I., Totolyan A. A., Gracheva N. M., Shmeleva E. A., Manuilov B. M., Lyutov A. G. Collective immunity to SARS-CoV-2 of Moscow residents during the COVID-19 epidemic period. Infekcionnye bolezni. 2020; 18(4): 8–16. doi: 10.20953/1729-9225-2020-4-8-16

16. Popova A. Yu., Yezhlova E. B., Melnikova A. A., Stepanova T. F., Sharukho G. V., Letyushev A. N., Vollmer A. Ya., Shepotkova A. A., Lyalina L. V., Smirnov V. S., Stepanova K. B., Panina Ts.A., Sidorenko O. N., Ivanova N. A., Smirnova S. S., Malchenko I. N., Okhotnikova E. V., Stakhova E. G., Totolyan A. A. Distribution of seroprevalence to Sars-cov-2 among residents of the Tyumen region in the epidemic period Covid-19. Zhurnal mikrobiologii, jepidemiologii i immunobiologii. 2020; 5: 392-400

17. Popova A. Yu., Yezhlova E. B., Melnikova A. A., Bashketova N. S., Fridman R. K., Lyalina L. V., Smirnov V. S., Chkhindzheria I. G., Grechaninova T. A., Agapov K. A., Arsentieva N. A., Bazhenova N. A., Batsunov O. K., Danilova E. M., Zueva E. V., Komkova D. V., Kuznetsova R. N., Lyubimova N. E., Markova A. N., Khamitova I. V., Lomonosova V. I., Vetrov V. V., Milichkina A.M., Dedkov V. G., Totolyan A. A. Population immunity to Sars-cov2 among the population of St. Petersburg during the Covid-19 epidemic. Problemy osobo opasnyh infekcij. 2020; 3:124-130.

18. Popova A. Yu., Yezhlova E. B., Melnikova A. A., Patyashina M. A., Sizova E. P., Yuzlibaeva L. R., Lyalina L. V., Smirnov V. S., Badamshina G. G., Goncharova A.V., Arbuzova T. V., Lomonosova V. I., Totolyan A. A. Characteristics of seroprevalence to Sars-cov-2 among the population of the Republic of Tatarstan against the background of Covid-19. Zhurnal mikrobiologii, jepidemiologii i immunobiologii. 2020; 6: 518-528.

19. Popova A. Yu., Yezhlova E. B., Melnikova A. A., Babura E. A., Mikheenko O. P., Lyalina L. V., Smirnov V. S., Molchanova Zh. R., Gorbatova Ya.V., Kharitonova M. N., Zubova A. N., Pogrebnaya T. N., Danilova V. I., Kukharchuk S. V., Dudinskaya E. V., Arbuzova T. V., Lomonosova V. I., Totolyan A. A. Population immunity to SARS-CoV-2 of the population Kaliningrad region in the epidemic season of COVID-19. Zhurnal Infektologii. 2020; 12 (5): 6271.

20. Pedro SA, Ndjomatchoua FT, Jentsch P, Tchuenche JM, Anand Mand Bauch CT (2020) Conditions for a second wave of Covid-19 due to interactions between disease dynamics and social processes. Front. Phys. 8:574514. doi: (10.3389) fghy.2020.574514)

21. Belyakov N. A., Bagnenko S. F., Rassokhin V. V., Trofimova T. N. The evolution of the COVID-19 pandemic. St. Petersburg: Baltijskij medicinskij obrazovatel'nyj centr. 2021: 410

22. Popova A. Yu., Andreeva E. E., Babura E. A., Balakhonov S. V., Bashketova N. S., Bulanov M. V., Valeullina N. N., Goryaev D. V., Detkovskaya N. N., Ezhlova E. B., Zaitseva N. N., Historian O. A., Kovalchuk I. V., Kozlovskikh D. N., Kombarova S. V., Kurganova O. P., Kutyrev V. V., Lomovtsev A. E., Lukicheva L. A., Lyalina L. V., Melnikova A. A., Mikailova O. M., Noskov A. K., Noskova L. N., Oglezneva E. E., Osmolovskaya T. P., Patyashina M. A., Penkovskaya N. A., Samoilova L. V., Smirnov V. S., Stepanova T. F., Trotsenko O. E., Totolyan A. A. Features of the formation of seroprevalence of the population of the Russian Federation to the SARS-CoV-2 nucleocapsid in the first wave of the COVID-19 epidemic. Infekcija i immunitet. 2021;11(2):297-323. https://doi.org/10.15789/2220-7619-FOD-1684

23. Nechaev V. V., Vasilyeva Yu. A., Tagirova E. Clinical and epidemiological characteristics of COVID-19 in St. Petersburg. Zhurnal infektologii. 2021; 13(1): 98-99.

24.Filatov N. N. Covid-19-quality control of anti-epidemic measures to protect the population. Izvestija GGTU Medicina-Farmacija. Nauchno-prakticheskij zhurnal. 2020; 2: 1014.

25. Pshenichnaya N. Yu., Lizinfeld I. A., Zhuravlev G. Yu., Ploskireva A. A., Akimkin V. G. The epidemic process of COVID-19 in the Russian Federation: interim results. Message 1. Infekcionnye bolezni. 2020; 18 (3): 7-14.

26. Сocciapaglia G., Cot C., Sannino F. Second wave COVID-19 pandemics in Europe: a temporal playbook. Sci Rep. 2020;10(1):15514. doi: 10.1038/s41598-020-72611-5.

27. Balakhonov S. V., Dubrovina V. I., Pentecostnikova A. B., Bryukhova D. D., Kiseleva N. O., Korytov K. M., Voytkova V. V., Perezhogin A. N., Chesnokova M. V., Gavrilova T. A., Seledtsov A. A. Dynamics of changes in population immunity to the SARSCoV-2 virus in residents of the Irkutsk region in the conditions of the COVID-19 pandemic. Jepidemiologija i Vakcinoprofilaktika. 2021;20(2):12-17. https://doi.org/10.31631/2073-30462021-20-2-12-17

28. Chemisova O. S. Noskov A. K., Kovalev E. V. et al. Dynamics of the formation of population immunity to SARS-CoV-2 in the Rostov region. Materials of the International Scientific and Practical Conference on Countering the new coronavirus infection and other infectious diseases. Saint Petersburg, 2020: 212-214.

29. Krasnov Ya. M., Popova A. Yu., Safronov V. A., Fedorov A.V., Badanin D. V., Shcherbakova S. A., Kutyrev V. V. Analysis of the genomic diversity of Sars-cov-2 and epidemiological signs of adaptation of the Covid-19 pathogen to the human population (message 1). Problemy osobo opasnyh infekcij. 2020; 3: 70-82.

30. Korber B., Fischer W.M., Ghanakaran S., Yoon Error! Hyperlink reference not valid. H., Theiler J, Abfalterer W, Hengartner N, Giorgi E.E. , Bhattacharya T., FoleyB., Hastie K.M. , Parker M.D. , Partridge D.G., Evans C.M. , Freeman T.M., Silva Th.I de , McDanal Ch. , Perez L.G., Tang H., Moon-Walker A., Whelan S.P., LaBranche C.C., Saphire E.O., Montefiori D.C. Tracking Changes in SARS-CoV-1 Spice: evidance that D614G increases infectivity of the Covid-19 virus. Cell. 2020; 182: 812-827. doi: 10.1016/j.cell.2020.06.043.

31. Wise J. COVID-19 – New coronavirus variant is identified in UK. BMJ. 2020; 371:m4857. doi:10/1136/bmj.m4857:pmid33328153.

32. Wang, P., Nair, M.S., Liu, L. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130–135 (2021). https://doi.org/10.1038/s41586-021-03398-2.

33. Challen R., Brocks-Polloch., Read J.M. et al. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1:matched cohort study. BMJ. 2021; 372 (579) doi:https://doi.org/10/1136/log.n579.

34. European Centre for disease Prevention and Control. Risk related to the spread of new SARS-CoV-2. Variants of concern in the EU/EEA-first update/ Stockholm; 21 Jan 2021.

35. Apea V.J., Wan Y.I., Dhairgawan R. et al. Ethnicity and outcomes in patients hospitalsed with COVID-19 infection in East London: an observational cohort study. Brit Med J.Open. 2020; 11(1).

Coronavirus infections are a group of diseases caused by viruses of zoonotic origin, characterized by polymorphic clinical evidence, adverse clinical and epidemiological consequences, widespread prevalence among animals and humans. Currently, the disease has acquired a predominantly anthroponotic character.

Despite the more than 50-year history since the discovery of the pathogens of coronavirus infection, the epidemiology of human diseases remains insufficiently studied. This primarily concerns the causes of the appearance, preservation of the virus, the dynamics of the emergence and spread of infection among people. The appearance of severe acute respiratory syndrome in people in 2002-2003 and Eastern Mediterranean Respiratory syndrome in 2012 and studying them have not radically changed our understanding of the key problems of epidemiology. The sudden emergence of the "new" COVID-19 coronavirus infection in China and its spread in the world caused the strongest destabilization of the economy, education systems, healthcare of all countries in the world, social tension in society.

Today, there are 7 known strains of coronaviruses that cause human diseases:

1. Сoronavirus (HCoV-NL63, New Haven coronavirus)

2. Сoronavirus HKU1

3. Coronavirus NL63 (HCoV-NL63, New Haven coronavirus)

4. Сoronavirus HKU1

5. Severe acute respiratory syndrome coronavirus (SARS-CoV) 2002-2003 г

6. Middle East respiratory syndrome-related coronavirus (MERS-CoV), also known as the new coronavirus of 2012 and HCoV-EMC

7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously named as 2019-nCoV , and now as СОVID 2019.

The first four strains cause mild acute respiratory diseases that, as a rule, remain etiologically undeciphered, the rest are famous coronavirus diseases with varying degrees of severity and adverse consequences.

The story of COVID-19 started in Wuhan, Hubei Province of central China, where cases of pneumonia of unknown aetiology were detected in late December 2019. The sick residents worked or bought food at the local market to sell animals and seafood. The official announcement of an outbreak of "atypical pneumonia" of unknown aetiology appeared on December 31, 2019 [1], although the first cases had been detected in China since December 8, 2019 [2,3]. The Chinese authorities informed the WHO about an outbreak of unknown pneumonia on December 31, 2019, and the city of Wuhan was quarantined. The isolation of the coronavirus, the spread of the disease on the territory of China, the importation of the disease to other countries and territories allowed the WHO Emergency Committee on January 30, 2020, to recognize the outbreak caused by the new coronavirus as a public health emergency of international concern [4]. Chinese scientists isolated the new coronavirus, originally named 2019-nCoV, and established 79.5% of the association of its genome sequence with the SARSCoV virus, which causes severe acute respiratory syndrome [5]. The new disease got its name, COVID-2019, on February 11, 2020. By the proposal of the WHO Committee of Experts, the coronavirus infection caused by the COVID-19 virus has been classified as a pandemic disease.

Для Цитирования:
Nechaev Vitaliy Vladimirovich, Lobzin Yuriy Vladimirovich, Gusev Denis Aleksandrovich, Vasilieva Yuliya Anatolievna, Vinogradova Nadezhda Valerievna, Tagirova Enzhe Rafikovna, Gorziy Egor Sergeevich, Pavlov Igor Alekseevich, Shirokova Anna Yurievna, Yaremchuk Mariya Sergeevna, Yatsenko Anastasiya Mikhailovna, Epidemiology of the current coronovirus infection: features and problems . Санитарный врач. 2021;9.
Полная версия статьи доступна подписчикам журнала
Язык статьи:
Действия с выбранными: